Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 82

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 82
---
 equity interests from our Existing Owners and will not be available to fund our operations.

We have granted the
underwriters an option to purchase up to an aggregate of additional shares of Class A Common Stock from us. We intend to use a portion of net proceeds received from the sale of additional shares to repurchase a portion of
the shares of Class A Common Stock held by Legence Investment Aggregator II and the remaining portion of such net proceeds from the sale of additional shares will be contributed to Legence Holdings in exchange for additional LGN Units, and
Legence Holdings will use such net proceeds to purchase LGN Units, together with an equal number of shares of Class B Common Stock, from Legence Investment Aggregator I (in each case, at a purchase price per LGN Unit and share of Class B
Common Stock, or per share of Class A Common Stock, as applicable, equal to the public offering price per share of Class A Common Stock in this offering, net of underwriting discounts and commissions). The proceeds will be used for such
purposes in proportion to the Legence Investment Aggregators’ respective ownership interest in Legence. For additional information, see “Use of Proceeds.” Accordingly, we will not retain any of these proceeds, and none of these
proceeds will be available to fund our operations, capital expenditures or acquisition opportunities.

51

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 There is no existing market for our Class A Common Stock, and a trading market that will provide you with adequate liquidity may not develop. The price of our Class A Common Stock may fluctuate significantly, and you could lose all or part of your investment. Prior to this offering, there has been no public market for our Class A Common Stock. After this offering, there will be only publicly traded shares of Class A Common Stock held by our public stockholders ( shares of Class A Common Stock if the underwriters exercise in full their option to purchase additional shares of Class A Common Stock). After this offering, our Sponsor will beneficially own (i) shares of Class A Common Stock, representing an aggregate % of outstanding shares of our Class A Common Stock (or % of outstanding shares of our Class A Common Stock if the underwriters exercise in full their option to purchase additional shares of Class A Common Stock and after giving effect to the application of the net proceeds therefrom), and (ii) shares of our Class B Common Stock (or shares of Class